Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study
Aslı Büyükkuşcu, Zehra Sucuoglu Isleyen, Ömer Burak Ekinci, Tugay Atasever et autres
ag, tr (code pays fourni par la source)